chr7-5480548-AT-A
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_024963.6(FBXL18):c.*1226delA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0012 ( 0 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
FBXL18
NM_024963.6 3_prime_UTR
NM_024963.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.827
Publications
0 publications found
Genes affected
FBXL18 (HGNC:21874): (F-box and leucine rich repeat protein 18) The protein encoded by this gene is a member of a family of proteins that contain an approximately 40-amino acid F-box motif. This motif is important for interaction with SKP1 and for targeting some proteins for degradation. The encoded protein has been shown to control the cellular level of FBXL7, a protein that induces mitotic arrest, by targeting it for polyubiquitylation and proteasomal degradation. Members of the F-box protein family, such as FBXL18, are characterized by an approximately 40-amino acid F-box motif. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL18 | NM_024963.6 | c.*1226delA | 3_prime_UTR_variant | Exon 5 of 5 | ENST00000382368.8 | NP_079239.3 | ||
FBXL18 | NM_001367780.1 | c.*1226delA | 3_prime_UTR_variant | Exon 5 of 5 | NP_001354709.1 | |||
FBXL18 | NM_001367781.1 | c.*1226delA | 3_prime_UTR_variant | Exon 5 of 5 | NP_001354710.1 | |||
FBXL18 | NM_001363441.2 | c.2000+10682delA | intron_variant | Intron 4 of 4 | NP_001350370.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00119 AC: 48AN: 40202Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
48
AN:
40202
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00119 AC: 48AN: 40190Hom.: 0 Cov.: 0 AF XY: 0.00128 AC XY: 23AN XY: 17958 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
48
AN:
40190
Hom.:
Cov.:
0
AF XY:
AC XY:
23
AN XY:
17958
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
12
AN:
10380
American (AMR)
AF:
AC:
2
AN:
2668
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1288
East Asian (EAS)
AF:
AC:
0
AN:
1848
South Asian (SAS)
AF:
AC:
0
AN:
1158
European-Finnish (FIN)
AF:
AC:
0
AN:
926
Middle Eastern (MID)
AF:
AC:
0
AN:
62
European-Non Finnish (NFE)
AF:
AC:
33
AN:
21038
Other (OTH)
AF:
AC:
1
AN:
540
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.278
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.